                         SEQUENCE LISTING

<110>  University of East Anglia
       Wormstone, Ian Michael
       Dawes, Lucy
       Eldred, Julie Ann
       Wang, Lixin
 
<120>  TREATMENT OF FIBROTIC EYE DISORDERS

<130>  P111094PC00

<150>  61/095,547
<151>  2008-09-09

<160>  8     

<170>  PatentIn version 3.3

<210>  1
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  MLCK inhibitor peptide 18


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  AMIDATION

<400>  1

Arg Lys Lys Tyr Lys Tyr Arg Arg Lys 
1               5                   


<210>  2
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  myristoylated EGF-R fragment (651-658) Protein Kinase C inhibitor


<220>
<221>  LIPID
<222>  (1)..(1)
<223>  MYRISTATE

<400>  2

Arg Lys Arg Thr Leu Arg Arg Leu 
1               5               


<210>  3
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  myristoylated Protein Kinase C inhibitor 20-28 cell permeable 
       Protein Kinase C inhibitor


<220>
<221>  LIPID
<222>  (1)..(1)
<223>  MYRISTATE

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  AMIDATION

<400>  3

Phe Ala Arg Lys Gly Ala Leu Arg Gln 
1               5                   


<210>  4
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Protein Kinase C inhibitor peptide 19-36

<400>  4

Arg Phe Ala Arg Lys Gly Ala Leu Arg Gln Lys Asn Val His Glu Val 
1               5                   10                  15      


Lys Asn 
        


<210>  5
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  Protein Kinase C-zeta/lota pseudosubstrate inhibitor; or Protein 
       Kinase C-zeta  pseudosubstrate inhibitor myristoylated


<220>
<221>  OPTIONALLY LIPID
<222>  (1)..(1)
<223>  MYRISTATE

<400>  5

Ser Ile Tyr Arg Arg Gly Ala Arg Arg Trp Arg Lys Leu 
1               5                   10              


<210>  6
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Protein Kinase C-theta pseudosubstrate inhibitor; or Protein 
       Kinase C-theta pseudosubstrate inhibitor myristoylated


<220>
<221>  OPTIONALLY LIPID
<222>  (1)..(1)
<223>  MYRISTATE

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  AMIDATION

<400>  6

Leu His Gln Arg Arg Gly Ala Ile Lys Gln Ala Lys Val His His Val 
1               5                   10                  15      


Lys Cys 
        


<210>  7
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Protein Kinase C-epsilon translocation inhibitor peptide

<400>  7

Glu Ala Val Ser Leu Lys Pro Thr 
1               5               


<210>  8
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  Protein Kinase C inhibitor peptide 19-31

<400>  8

Arg Phe Ala Arg Lys Gly Ala Leu Arg Gln Lys Asn Val 
1               5                   10              


